Price as of close on Nov 3, 2026 · Financials updated Oct 6, 2026
Basics
Sector
Basic Materials
Industry
Specialty Chemicals
Country
United States
Market cap
2.0B USD
Enterprise value
5.2B USD
Full-time employees
5,700
Overall health
Drawback:less profitable than most peersless profitable than peers
Drawback:its shares are priced higher than most peers relative to what it earnspriced higher than peers for its earnings
Drawback:higher risk than most peers: its share price swings more than most peers’ (beta 1.40 vs a peer median of 0.69)higher risk: bigger price swings (beta 1.40 vs peers 0.69)
About average: growth
Ranks #1,114 of 1,217 basic materials companies (bottom 9%)
Negative shareholders' equity. Liabilities exceed assets on the balance sheet.
Chemours's liabilities exceed its assets on the balance sheet. Large share buybacks can cause this in healthy companies, but so can accumulated losses; either way, debt-based ratios need care.
Valuation signals disagree. Cheaper than 85% of peers on free cash flow, but only 0% on earnings.
Relative to its free cash flow, Chemours looks cheaper than 85% of peers; relative to its earnings, cheaper than only 0%. The valuation score blends the two, so look at which measure fits this business best.
Not profitable yet. Reported a loss in the 12 months to June 2026.
Chemours reported a net loss over the last twelve months, so earnings-based measures can't show it as cheap.
More volatile share price. Beta 1.40: tends to move more than the market.
Chemours's shares have swung more with the market than most peers' (beta 1.40, above the market's 1.0).
Sector-normalized EBITDA, earnings, and free cash flow yields.
Earnings yield-15.4%
SEC filings · 12 months to Jun 2026Negative (a loss or cash outflow), so it counts as zero whatever the share price30% base weight · Z-score -1.00Sector median: 0.0364 · MAD: 0.0364
EBITDA yield-0.9%
SEC filings · 12 months to Jun 2026Negative (a loss or cash outflow), so it counts as zero whatever the share price50% base weight · Z-score -1.64Sector median: 0.0854 · MAD: 0.0520
Free cash flow yield11.1%
SEC filings · 12 months to Jun 2026 · operating cash flow − capital spendingReported value20% base weight · Z-score 3.24Sector median: 0.0261 · MAD: 0.0261
Why it changed since the Oct 27, 2026 close: Score 7 → 8
Peer companies moved+1
Each step re-scores the company against its peers as they were on Oct 28, 2026; the parts add up to the change. Price effects on EBITDA yield are approximate.
Shareholders' equity is negative, so debt/equity counts as among the highest in its peer group33% base weight · Z-score -4.82Sector median: 0.3578 · MAD: 0.2929
Valuation, growth and profitability scores: higher is better. Risk: 0 is lower, 2 is higher. Risk is a relative proxy, not a bankruptcy probability. Scores depend on available sector peers.
Questions investors ask about Chemours
Is Chemours getting weaker?
Its latest SEC filing (Aug 5, 2026) showed no major changes. Its overall score is unchanged at 22/100 since Oct 28, 2026.
How is Chemours valued vs its peers?
Priced higher than most peers relative to what it earns. Valuation scores 36/100 against 1,371 basic materials peers.Free cash flow yield 11.1% vs a peer median of 2.6% (stronger than 85% of peers).Free cash flow yield 11.1% vs peers 2.6% (stronger than 85% of peers).Earnings yield -15.4% vs a peer median of 3.6% (weaker than 100% of peers).Earnings yield -15.4% vs peers 3.6% (weaker than 100% of peers).
Is Chemours growing?
At about the same pace as its peers. Growth scores 43/100 against 1,371 basic materials peers.Revenue growth -0.9% vs a peer median of 3.4% (weaker than 63% of peers).Revenue growth -0.9% vs peers 3.4% (weaker than 63% of peers).
How profitable is Chemours?
Less profitable than most of its peers. Profitability scores 8/100 against 1,371 basic materials peers.Return on invested capital -9.1% vs a peer median of 6.7% (weaker than 94% of peers).Return on invested capital -9.1% vs peers 6.7% (weaker than 94% of peers).
How risky is Chemours?
Higher risk relative to 1,371 basic materials peers, judged on debt, liquidity and share-price swings.Beta 1.40 vs a peer median of 0.69 (weaker than 89% of peers).Beta 1.40 vs peers 0.69 (weaker than 89% of peers). A relative measure, not a bankruptcy probability.
Latest filing: what changed
Quarter ended Jun 30, 2026 · filed Aug 5, 2026 · compared with the quarter ended Mar 31, 2026
No major changes
Worth watching: Chemours is in the bottom fifth of its sector on profitability. From 2021 to 2025, 63% of companies in that position posted a loss over the following year, against 4% for the top fifth.
Previous quarter
Latest quarter
Change
Revenue (12 months)
5.8B USD
5.8B USD
−0.4%
Net income (12 months)
−410.0M USD
−304.0M USD
−25.9%
Operating margin
-5.9%
-6.3%
−0.4 pts
Free cash flow (12 months)
154.0M USD
218.0M USD
+41.6%
Debt
4.2B USD
3.9B USD
−6.4%
Cash
563.0M USD
671.0M USD
+19.2%
Shares outstanding
150.4M
150.5M
+0.1%
From the company’s own SEC filings, as filed. Twelve-month figures roll forward one quarter at a time.
Industry valuation context
Industry: Specialty Chemicals · 32 companies
Valuations in Specialty Chemicals are above their usual range since 2016.
74% of months since 2016 were valued lower than now.
17% of companies are in the most expensive fifth of their own price-to-sales history.
Over 24 months, company values −8% and earnings +13% (medians): earnings grew faster than prices.
Median price-to-sales is −36% vs the whole market, against a usual −31%.
2016Shaded: most expensive fifth of its range2026
This is a cyclical group: after a downturn, trailing earnings and sales fall faster than prices, which can make valuations look high near a cycle's low.
Describes valuations since 2016; it does not predict prices. US companies worth $1B+, from SEC filings and month-end prices, as of Aug 2026. Today's companies and industry labels are used throughout. Measured on earnings, EBITDA, sales and free cash flow yields. How this works
Financials
Fiscal years from SEC annual filings · change vs the prior year
Key ratios
FY 2021
FY 2022
FY 2023
FY 2024
FY 2025
Change
Gross margin
21.8%
23.7%
21.4%
19.8%
15.5%
▼ 4.2 pts
Operating margin
8.1%
9.8%
-6.7%
1.7%
-5.2%
▼ 6.9 pts
Net margin
9.6%
8.5%
-4.2%
1.2%
-6.6%
▼ 7.8 pts
Return on assets (ROA)
8.1%
7.6%
-3.1%
0.9%
-5.2%
▼ 6.1 pts
Return on equity (ROE)
56.2%
52.2%
-35.1%
12.1%
-154.4%
▼ 166 pts
Free cash flow margin
8.5%
6.6%
3.1%
-17.2%
0.9%
▲ 18 pts
Current ratio
1.80×
1.70×
1.55×
1.66×
1.78×
▲ 7.4%
Quick ratio
1.21×
0.96×
1.00×
0.85×
0.85×
▼ 0.5%
Debt to equity
3.50×
3.31×
5.66×
7.28×
16.73×
▲ 130%
Interest coverage
2.77×
4.12×
-1.97×
0.37×
-1.13×
▼ 402%
CC price history
Price history is added with the daily price update and will appear after the next one.